<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Alterity Therapeutics Limited

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Alterity Therapeutics Limited

    We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases. Alterity Therapeutics was incorporated in Melbourne, Australia in 1997 as Prana Biotechnology and has offices in Melbourne, Australia, and San Francisco, USA. The Company listed on the Australian Securities Exchange in 2000 and listed on the NASDAQ in 2002. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Geoffrey Kempler
    • FOUNDED
      1997
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Cellular Biomedicine Group, Inc.

    Cellular Biomedicine Group, Inc.

    Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) develops proprietary cell therapie...

    Cellular Biomedicine Group, Inc. (NASDAQ: CBMG)...

    Filing Type:    PU
    Cassava Sciences, Inc.

    Cassava Sciences, Inc.

    The mission of Cassava Sciences is to detect and treat neurodegenerative diseases,...

    The mission of Cassava Sciences is to detect an...

    Filing Type:    PU
    Carie Health Inc.

    Carie Health Inc.

    Carie Health is a mobile healthcare solution that allows members to connect with a...

    Carie Health is a mobile healthcare solution th...

    Amount Raised:    $7,000,000
    Fundraising Status:    SA
    Filing Type:    CF
    Assembly Biosciences, Inc.

    Assembly Biosciences, Inc.

    Assembly Biosciences is advancing a new class of oral therapeutics for the treatme...

    Assembly Biosciences is advancing a new class o...

    Filing Type:    PU
    NeurMedix Inc.

    NeurMedix Inc.

    NeurMedix, Inc., is a clinical-stage biotechnology company that engages in develop...

    NeurMedix, Inc., is a clinical-stage biotechnol...

    Fundraising Status:    EC
    Filing Type:    RA
    AzurRx BioPharma, Inc.

    AzurRx BioPharma, Inc.

    AzurRx BioPharma is a development stage biopharmaceutical company (NASDAQ: AZRX) f...

    AzurRx BioPharma is a development stage biophar...

    Filing Type:    PU
    Denali Therapeutics Inc.

    Denali Therapeutics Inc.

    We discover and develop medicines to defeat neurodegeneration. The science is brea...

    We discover and develop medicines to defeat neu...

    Filing Type:    PU
    Prevail Therapeutics Inc.

    Prevail Therapeutics Inc.

    Prevail Therapeutics is applying precision medicine to the development of gene the...

    Prevail Therapeutics is applying precision medi...

    Filing Type:    PU
    Cortexyme, Inc.

    Cortexyme, Inc.

    Cortexyme is a biopharmaceutical company developing therapeutics based on data sup...

    Cortexyme is a biopharmaceutical company develo...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.